Professional Role, Ethics, and Legal Issues in Advanced Practice Oncology Nursing Flashcards

A patient with metastatic lung cancer has previously completed a POLST (Physician Orders for Life-Sustaining Treatment) form indicating DNR/DNI status. During a hospitalization, the patient's adult daughter insists the team 'do everything possible.' What is the oncology NP's most appropriate action?

Answer: Honor the patient's documented POLST, which reflects the patient's own autonomous choices

A POLST is a legally recognized medical order reflecting the patient's autonomous wishes regarding life-sustaining treatment. It supersedes family preferences when the patient lacks current decision-making capacity and previously had capacity when completing the form. The patient's documented autonomous choice must be respected. Family members do not override a valid POLST. Ethics consultation can be considered for ongoing family conflict but is not required before honoring the existing legal order.

When obtaining informed consent for a Phase I oncology clinical trial, which element distinguishes informed consent in this context from standard treatment consent?

Answer: Patients must be informed that the primary purpose is to determine safety and dose, not to achieve tumor response

A critical and ethically mandated element of Phase I trial consent is explicitly informing participants that the primary objective is to evaluate safety, pharmacokinetics, and determine the maximum tolerated dose — not to provide therapeutic benefit. This distinction addresses therapeutic misconception, where participants mistakenly believe the trial is primarily designed to help them. Consent cannot be waived for competent adults. A competent adult must consent personally. Withdrawal of consent is always permitted.

An oncology NP suspects a colleague is documenting chemotherapy administration that was not actually performed. Which action represents the NP's primary professional and legal obligation?

Answer: Report the concern through the institution's established reporting chain or compliance office

Documenting care that was not performed constitutes healthcare fraud and potentially endangers patient safety. The NP's professional and legal obligation — as articulated in ANA and ONCC standards — is to report the concern through established institutional channels (charge nurse, manager, compliance hotline, or risk management) without delay. Confronting the colleague privately may allow continued misconduct. Waiting for more evidence delays patient protection. Contacting the family directly bypasses proper institutional process.

Which ethical principle is most prominently invoked when an oncology NP advocates for a patient's right to refuse further chemotherapy despite family pressure to continue treatment?

Answer: Autonomy

Autonomy — the right of a competent individual to make decisions about their own body and care without coercion — is the core principle at stake when honoring a patient's informed refusal of treatment. Beneficence refers to acting in the patient's best interest. Non-maleficence means avoiding harm. Justice involves fair distribution of resources. Advocacy for a patient's treatment refusal against external pressure is a classic application of respecting autonomy.

Under the Oncology Nursing Society's (ONS) standards, which activity falls within the established scope of practice for an AOCNP in most states?

Answer: Prescribing chemotherapy regimens within a collaborative practice model

AOCNPs practice within advanced practice registered nurse (APRN) scope, which in most states includes independent or collaborative prescribing of medications, including chemotherapy, within an established oncology practice framework and collaborative agreements where required. Surgical procedures, pathology interpretation, and transplant procedures fall within physician (surgeon, pathologist, transplant physician) scope of practice and are not within NP scope regardless of certification.

A hospital implements a new protocol for managing chemotherapy-induced nausea and vomiting (CINV). The oncology NP leads the quality improvement (QI) project. Which framework is most appropriate for structuring iterative improvement cycles in this project?

Answer: PDSA (Plan-Do-Study-Act) cycle

The PDSA (Plan-Do-Study-Act) cycle is the standard QI methodology for testing and implementing iterative improvements in clinical practice, endorsed by IHI and commonly used in oncology QI initiatives. SWOT analysis assesses organizational strengths/weaknesses but doesn't drive improvement cycles. RCA is a retrospective tool for analyzing adverse events. FMEA is a prospective risk assessment tool used in process safety, not iterative protocol improvement.